In vitro susceptibility and distribution of beta-lactamases in Enterobacteriaceae causing intra-abdominal infections in North America 2010-2011

Diagnostic Microbiology and Infectious Disease

Volumn 79, Issue 3, 2014, Pages 367-372

  Hoban, Daryl J ^a   Badal, Robert ^a   Bouchillon, Sam ^a   Hackel, Meredith ^a   Kazmierczak, Krystyna ^a   Lascols, Christine ^a   Hawser, Stephen ^b  

^a Division of Microbiology   (United States)

^b International Health Management Associates Europe Sàrl   (Switzerland)

Author keywords

Beta lactamase; Enterobacteriaceae; Resistance

Indexed keywords

AMIKACIN; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; BETA LACTAMASE GENE; BLAAMPC GENE; BLACTX M GENE; BLAKPC GENE; BLASHV GENE; CITROBACTER FREUNDII; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ENZYME LOCALIZATION; ENZYME SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; INCIDENCE; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MORGANELLA MORGANNII; NONHUMAN; NORTH AMERICA; PRIORITY JOURNAL; PROTEUS MIRABILIS; SERRATIA MARCESCENS; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; FEMALE; GENETICS; HUMAN; MALE; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; INTRAABDOMINAL INFECTIONS; MALE; MICROBIAL SENSITIVITY TESTS; NORTH AMERICA;

EID: 84902120635     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2014.03.026     Document Type: Article

References (18)

1. Brink S.J., Botha R.F., Poswa X., Senekal M., Badal R.E., Grolman D.C., et al. Antimicrobial susceptibility of gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints. Surg Infect 2012, 13(1):43-49.
2. Cantón R., Novais A., Valverde A., Machado E., Peixe L., Baquero F., et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14(Suppl. 1):144-153.
3. Cantón R., Akóva M., Carmeli Y., Giske C.G., Glupczynski Y., Gniadkowski M., et al. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012, 18:413-431.
4. Chen Y.H., Hsueh P.R. Changing bacteriology of abdominal and surgical sepsis. Curr Opin Infect Dis 2012, 25(5):590-595.
5. Chen Y.H., Hsueh P.R., Badal R.E., Hawser S.P., Hoban D.J., Bouchillon S.K., et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect 2011, 62(4):280-291.
6. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing. Twenty-Second informational supplement. Document M100-S22 2012, CLSI, Wayne, PA.
7. Hawser S.P., Bouchillon S.K., Hoban D.J., Badal R.E., Cantón R., Baquero F. Incidence and Antimicrobial Susceptibility of Escherichia coli and Klebsiella pneumoniae with Extended-Spectrum β-Lactamases in Community- and Hospital-Associated Intra-Abdominal Infections in Europe: Results of the 2008 Study for Monitoring Antimicrobial Resistance Trends (SMART). Antimicrob Agents Chemother 2010, 54(7):3043-3046.
8. Hawser S., Hoban D., Bouchillon S., Badal R., Carmeli Y., Hawkey P. Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008. Eur J Clin Microbiol Infect Dis 2011, 30:173-179.
9. Hoban D.J., Bouchillon S.K., Hawser S.P., Badal R.E., LaBombardi V.J., DiPersio J. Susceptibility of gram-negative pathogens isolated from complicated intra-abdominal infections in the United States 2007-2008: Results of the SMART Study. Antimicrob Agents Chemother 2010, 54:3031-3034.
10. Jacoby G.A. AmpC β-lactamases. Clin Microbiol Rev 2009, 22(1):161-182.
11. Jacoby G.A., Mills D.M., Chow N. Role of β-lactamases and porins in resistance to ertapenem and other β-lactams in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004, 48(8):3203-3206.
12. Kiratisin P., Chongthaleong A., Tan T.Y., Lagamayo E., Roberts S., Garcia J., et al. Comparative in vitro activity of carbapenems against major Gram-negative pathogens: results of Asia-Pacific surveillance from the COMPACT II study. Int J Antimicrob Agents 2010, 39(4):311-316.
13. Lascols C., Hackel M., Hujer A.M., Marshall S.H., Bouchillon S.K., Hoban D.J., et al. Using nucleic acid microarrays to perform molecular epidemiology and detect novel β-lactamases throughout the world. J Clin Microbiol 2012, 50(5):1632-1639.
14. Nordmann P., Cornaglia G. Carbapenemase-producing Enterobacteriaceae: a call for action!. Clin Microbiol Infect 2012, 18(5):411-412.
15. Pitout J.D.D., Laupland K.B. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8:159-166.
16. Solomkin J.S., Muzaski J.E., Bradley J.S., Rodvold K.A., Goldstein E.J.C., Baron E.J., et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:133-164.
17. Tzouvelekis L.S., Markogiannakis A., Psichogiou M., Tassios P.T., Daikos G.L. Carbapenemases in Klebsiella pneumoniae and other Enterobacateriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 2012, 25(4):682-707.
18. Yang Q., Wang H., Sun H., Chen H., Xu Y., Chen M. Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems: results from large hospital-based surveillances in China. Antimicrob Agents Chemother 2010, 54(1):573-577.